Internet therapy for obesity shows promise in new study
NCT ID NCT05149950
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests an internet-based treatment program for adults with obesity. The program includes 12 modules over six months, focusing on lifestyle changes and weight control. Researchers want to see if it improves quality of life and leads to weight loss. About 100 people are taking part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- internet-based behavioral treatment program
- What this could lead to
- If it works, this could offer a convenient, scalable way to help people with obesity improve their quality of life and manage weight.
- What could go wrong
- This is a small, early-stage study with no control group for comparison. Dropout rates were high in the pilot, so many participants may not complete the program.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2022
- Expected to finish
-
Nov 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BMI 30-44.9 kg / m2 * BMI 28-29.9 kg / m2 and hypertension * BMI 28-29.9 kg / m2 and prediabetes * BMI 28-29.9 kg / m2 and type 2 diabetes * BMI 28-29.9 kg / m2 and coronary heart disease * BMI 28-29.9 kg / m2 and hyperlipidemia * BMI 28-29.9 kg / m2 and hepatic steatosis * BMI 28-29.9 kg / m2 and sleep apnea * BMI 28-29.9 kg / m2 and polycystic ovary syndrome Exclusion Criteria: * Severe mental illness * Ongoing or suspected eating disorder * Pregnancy * Breastfeeding * Cancer in active treatment * Use of drugs for weight loss * Weight loss treatment during the past 6 months * Active abuse of alcohol or drugs * Not being able to express themselves in Swedish in speech and writing * If the study supervisor deems that participation in the study is inappropriate for another reason.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stefan Jansson
Örebro, 70116, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- A pill for obesity? early human trial puts MDR-001 to the test
- Can a weekly shot help people who still struggle with weight after bariatric surgery?
- Do GLP-1 Weight-Loss drugs change how teens eat and feel?
- Can electrical muscle stimulation boost exercise benefits after menopause?
- Can a cold cloth on the neck calm Post-Surgery nausea?